journal
Journals Pharmacoepidemiology and Drug ...

Pharmacoepidemiology and Drug Safety

https://read.qxmd.com/read/38629241/comorbidity-influence-in-observational-studies-why-ignore-the-real-world
#1
JOURNAL ARTICLE
Victor A Kiri, Maurille Feudjo -Tepie
No abstract text is available yet for this article.
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38629216/updated-core-competencies-in-pharmacoepidemiology-to-inform-contemporary-curricula-and-training-for-academia-government-and-industry
#2
JOURNAL ARTICLE
Vicki Osborne, Amie Goodin, Joshua Brown, Almut G Winterstein, Andrew Bate, Catherine Cohet, Lisa Pont, David Moeny, Olaf Klungel, Simone Pinheiro, John Seeger, K Arnold Chan, Stanley Edlavitch, Hugh Tilson, Deborah Layton
PURPOSE: The first paper to specify the core content of pharmacoepidemiology as a profession was published by an ISPE (International Society for Pharmacoepidemiology) workgroup in 2012 (Jones JK et al. PDS 2012; 21[7]:677-689). Due to the broader and evolving scope of pharmacoepidemiology, ISPE considers it important to proactively identify, update and expand the list of core competencies to inform curricula of education programs; thus, better positioning pharmacoepidemiologists across academic, government (including regulatory), and industry positions...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38575389/clarifying-the-causal-contrast-an-empirical-example-applying-the-prevalent-new-user-study-design
#3
JOURNAL ARTICLE
Jessica C Young, Michael Webster-Clark, Shahar Shmuel, Elizabeth M Garry, Panagiotis Mavros, Til Stürmer, Cynthia J Girman
PURPOSE: The prevalent new user design extends the active comparator new user design to include patients switching to a treatment of interest from a comparator. We examined the impact of adding "switchers" to incident new users on the estimated hazard ratio (HR) of hospitalized heart failure. METHODS: Using MarketScan claims data (2000-2014), we estimated HRs of hospitalized heart failure between patients initiating GLP-1 receptor agonists (GLP-1 RA) and sulfonylureas (SU)...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38566351/validation-of-alopecia-coding-in-us-claims-data-among-women-of-childbearing-age
#4
REVIEW
Maria C Schneeweiss, Arash Mostaghimi, Stephanie Chiuve, Sebastian Schneeweiss, Priyanka Anand, Katharina Schoder, Theresa Oduol, Carrie Huisingh, Kueiyu Joshua Lin
BACKGROUND: Accurately identifying alopecia in claims data is important to study this rare medication side effect. OBJECTIVES: To develop and validate a claims-based algorithm to identify alopecia in women of childbearing age. METHODS: We linked electronic health records from a large healthcare system in Massachusetts (Mass General Brigham) with Medicaid claims data from 2016 through 2018 to identify all women aged 18 to 50 years with an ICD-10 code for alopecia, including alopecia areata, androgenic alopecia, non-scarring alopecia, or cicatricial alopecia, from a visit to the MGB system...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38565527/prevalence-of-self-medication-practices-among-pregnant-women-in-india-a-systematic-review-and-meta-analysis
#5
REVIEW
Vaibhav Chaudhary, Sweta Kumari, Navneet Khurana, Mohammad Azharuddin, Aditya Pratap Singh, Varsha Devi, Deepali Dhir, Biplab Pal
BACKGROUND: Self-medication practice among pregnant women is a global concern. However, its understanding in the Indian context is limited due to a lack of comprehensive studies. PURPOSE: This study aimed to comprehensively assess the prevalence of self-medication, the medications used for self-medication, diseases/conditions associated with self-medication, and the reasons for self-medication among Indian pregnant women. METHODS: This study was carried out following the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38565526/validity-of-inpatient-electronic-health-record-based-measures-of-oxygen-related-therapy-in-the-united-states-lessons-applicable-for-studying-covid-19-endpoints
#6
JOURNAL ARTICLE
Candace C Fuller, Edward Rosen, Ashish Rai, Austin Cosgrove, Karla Miller, Patricia Bright, Katherine Haffenreffer, Russell E Poland, Natasha Pratt, Kenneth Sands, Mayura U Shinde, Richard Platt, Noelle M Cocoros, Michael Klompas, Sarah K Dutcher
INTRODUCTION: During the COVID-19 pandemic, inpatient electronic health records (EHRs) have been used to conduct public health surveillance and assess treatments and outcomes. Invasive mechanical ventilation (MV) and supplemental oxygen (O2 ) use are markers of severe illness in hospitalized COVID-19 patients. In a large US system (n = 142 hospitals), we assessed documentation of MV and O2 use during COVID-19 hospitalization in administrative data versus nursing documentation...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38565524/percutaneous-left-atrial-appendage-occlusion-and-risk-of-stroke-hospitalized-bleeding-and-death-in-medicare-beneficiaries
#7
JOURNAL ARTICLE
Wendy Wang, Lin Yee Chen, Rob F Walker, Alvaro Alonso, Faye L Norby, Kamakshi Lakshminarayan, Pamela L Lutsey
PURPOSE: Among patients with atrial fibrillation (AF), a nonpharmacologic option (e.g., percutaneous left atrial appendage occlusion [LAAO]) is needed for patients with oral anticoagulant (OAC) contraindications. Among beneficiaries in the Medicare fee-for-service coverage 20% sample databases (2015-18) who had AF and an elevated CHA2 DS2 -VASc score, we assessed the association between percutaneous LAAO versus OAC use and risk of stroke, hospitalized bleeding, and death. METHODS: Patients undergoing percutaneous LAAO were matched to up to five OAC users by sex, age, date of enrollment, index date, CHA2 DS2 -VASc score, and HAS-BLED score...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38556924/validity-of-icd-10-based-algorithms-to-identify-patients-with-influenza-in-inpatient-and-outpatient-settings
#8
JOURNAL ARTICLE
Kirk Benack, Abner Nyandege, Edward Nonnenmacher, Saira Jan, Soko Setoguchi, Tobias Gerhard, Brian L Strom, Daniel B Horton
PURPOSE: To evaluate the validity of ICD-10-CM code-based algorithms as proxies for influenza in inpatient and outpatient settings in the USA. METHODS: Administrative claims data (2015-2018) from the largest commercial insurer in New Jersey (NJ), USA, were probabilistically linked to outpatient and inpatient electronic health record (EHR) data containing influenza test results from a large NJ health system. The primary claims-based algorithms defined influenza as presence of an ICD-10-CM code for influenza, stratified by setting (inpatient/outpatient) and code position for inpatient encounters...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38556843/validating-claims-based-definitions-for-deprescribing-bridging-the-gap-between-clinical-and-administrative-data
#9
JOURNAL ARTICLE
Joshua D Niznik, Shahar Shmuel, Virginia Pate, Carolyn T Thorpe, Laura C Hanson, Colleen Rice, Jennifer L Lund
BACKGROUND: Limited research has evaluated the validity of claims-based definitions for deprescribing. OBJECTIVES: Evaluate the validity of claims-based definitions of deprescribing against electronic health records (EHRs) for deprescribing of benzodiazepines (BZDs) after a fall-related hospitalization. METHODS: We used a novel data linkage between Medicare fee-for-service (FFS) and Part D with our health system's EHR. We identified patients aged ≥66 years with a fall-related hospitalization, continuous enrollment in Medicare FFS and Part D for 6 months pre- and post-hospitalization, and ≥2 BZD fills in the 6 months pre-hospitalization...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38556812/increase-transparency-and-reproducibility-of-real-world-evidence-in-rare-diseases-through-disease-specific-federated-data-networks
#10
REVIEW
Valerie van Baalen, Eva-Maria Didden, Daniel Rosenberg, Kristina Bardenheuer, Michel van Speybroeck, Monika Brand
PURPOSE: In rare diseases, real-world evidence (RWE) generation is often restricted due to small patient numbers and global geographic distribution. A federated data network (FDN) approach brings together multiple data sources harmonized for collaboration to increase the power of observational research. In this paper, we review how to increase reproducibility and transparency of RWE studies in rare diseases through disease-specific FDNs. METHOD: To be successful, a multiple stakeholder scientific FDN collaboration requires a strong governance model in place...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38527971/design-and-validation-of-algorithms-to-identify-venous-thromboembolism-in-the-french-national-healthcare-database
#11
JOURNAL ARTICLE
Nicolas H Thurin, Angela Grelaud, Adeline Grolleau, Marie-Agnès Bernard, Emmanuelle Bignon, Patrick Blin, Régis Lassalle, Cécile Droz-Perroteau
PURPOSE: This paper aims to introduce an algorithm designed to identify Venous Thromboembolism (VTE) in the French National Healthcare Database (SNDS) and to estimate its positive predictive value. METHODS: A case-identifying algorithm was designed using SNDS inpatient and outpatient encounters, including hospital stays with discharge diagnoses, imaging procedures and drugs dispensed, of French patients aged at least 18 years old to whom baricitinib or Tumor Necrosis Factor Inhibitors (TNFi) were dispensed between September 1, 2017, and December 31, 2018...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38511251/consistency-between-the-national-patient-register-and-the-swedish-cancer-register
#12
JOURNAL ARTICLE
Sakura Sakakibara, Laura Pazzagli, Marie Linder
PURPOSE: The Swedish National Patient Register (NPR) is widely used as a data source in epidemiological studies, but the consistency of all cancer diagnoses compared to the Swedish Cancer Register (SCR) remains unclear. Using NPR supplementary for detecting safety signals is beneficial due to shorter data extraction delays compared to using SCR alone. This study aims to evaluate the consistency of NPR for cancer diagnoses compared to SCR and its potential use in pharmacoepidemiology. METHODS: Patients with a cancer diagnosis recorded in SCR during 2018-2020 were included...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38511244/utilization-of-broad-versus-narrow-spectrum-antibiotics-for-the-treatment-of-outpatient-community-acquired-pneumonia-among-adults-in-the-united-states
#13
JOURNAL ARTICLE
Katelin B Nickel, Michael J Durkin, Margaret A Olsen, John M Sahrmann, Elizabeth Neuner, Caroline A O'Neil, Anne M Butler
PURPOSE: To characterize antibiotic utilization for outpatient community-acquired pneumonia (CAP) in the United States. METHODS: We conducted a cohort study among adults 18-64 years diagnosed with outpatient CAP and a same-day guideline-recommended oral antibiotic fill in the MarketScan® Commercial Database (2008-2019). We excluded patients coded for chronic lung disease or immunosuppressive disease; recent hospitalization or frequent healthcare exposure (e...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38511239/effects-of-the-valsartan-recall-on-heart-failure-patients-a-nationwide-analysis
#14
JOURNAL ARTICLE
Joshua W Devine, Mina Tadrous, Inmaculada Hernandez, Nandita Mukhopadhyay, Scott D Rothenberger, Katherine Callaway Kim, Walid F Gellad, Katie J Suda
BACKGROUND: Valsartan is commonly used for cardiac conditions. In 2018, the Food and Drug Administration recalled generic valsartan due to the detection of impurities. Our objective was to determine if heart failure patients receiving valsartan at the recall date had a greater likelihood of unfavorable outcomes than patients using comparable antihypertensives. METHODS: We conducted a cohort study of Optum's de-identified Clinformatics® Datamart (July 2017-January 2019)...
April 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38479400/medicine-utilization-studies-in-australian-individual-level-dispensing-data-a-blinded-multi-center-replicated-analysis
#15
JOURNAL ARTICLE
Malcolm B Gillies, Chrianna Bharat, Ximena Camacho, Benjamin Daniels, Kelly Hall, Thu-Lan Kelly, Erin Kelty, Jialing Lin, Melisa Litchfield, Derrick Lopez, Firouzeh Noghrehchi, Jacques Raubenheimer, Bianca Varney, Nicole Pratt
PURPOSE: Medicine dispensing data require extensive preparation when used for research and decisions during this process may lead to results that do not replicate between independent studies. We conducted an experiment to examine the impact of these decisions on results of a study measuring discontinuation, intensification, and switching in a cohort of patients initiating metformin. METHODS: Four Australian sites independently developed a HARmonized Protocol template to Enhance Reproducibility (HARPER) protocol and executed their analyses using the Australian Pharmaceutical Benefits Scheme 10% sample dataset...
March 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38453354/an-open-source-implementation-of-tree-based-scan-statistics
#16
JOURNAL ARTICLE
Massimiliano Russo, Shirley V Wang
PURPOSE: We develop an open-source R package to implement tree-based scan statistics (TBSS) analyses. METHODS: TBSS are data mining methods used by the United States Food and Drug Administration and the Centers for Disease Control. They simultaneously screen thousands of hierarchically aggregated outcomes to identify unsuspected adverse effects of drugs or vaccines, accounting for multiple comparisons. The general structure of TBSS is highly adaptable, with four essential components: (1) a hierarchical outcome structure, (2) a test statistic to be computed for each element of the hierarchy, (3) an algorithm to generate data replicates under a null distribution, and (4) observed outcomes at the lower level of the hierarchy...
March 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38450934/is-the-sequence-ratio-an-unbiased-estimate-of-the-incidence-rate-ratio-a-simulation-study
#17
JOURNAL ARTICLE
Thomas Delvin, Sofie Egsgaard, Jesper Hallas, Helene Kildegaard, Lars Christian Lund, Martin Torp Rahbek
PURPOSE: We aimed to evaluate the conditions under which the sequence ratio (SR) obtained from a sequence symmetry analysis is an unbiased estimate of the true incidence rate ratio (IRR). METHODS: We simulated cohorts of 1 million individuals who could initiate an exposure drug and experience a very rare, rare, common, or frequent outcome of interest. The outcome rate among exposed individuals was modified by a true incidence rate ratio of 0.2, 0.5, 1.0, 2.0, and 5...
March 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38450806/effect-of-statin-treatment-on-the-risk-of-cancer-in-patients-with-heart-failure-a-target-trial-emulation-study
#18
JOURNAL ARTICLE
Chengsheng Ju, Wallis C Y Lau, Pinkie Chambers, Kenneth K C Man, Martin D Forster, Isla S Mackenzie, Charlotte Manisty, Li Wei
PURPOSE: A recent observational study suggested statins could reduce cancer diagnosis in patients with heart failure (HF). The findings need to be validated using robust epidemiological methods. This study aimed to evaluate the effect of statin treatment on the risk of cancer in patients with HF. METHODS: We conducted two target trial emulations using primary care data from IQVIA Medical Research Database-UK (2000 to 2019) with a clone-censor-weight design. The first emulated trial addressed the treatment initiation effect: initiating within 1 year versus not initiating a statin after the HF diagnosis...
March 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38449020/comparing-the-centers-for-medicare-and-medicaid-services-cms-enrollment-data-death-dates-to-the-national-death-index-ndi
#19
JOURNAL ARTICLE
Dinci Pennap, Richard S Swain, Sandia Akhtar, Jiemin Liao, Yuqin Wei, Jiaqi Li, Michael Wernecke, Thomas E MaCurdy, Jeffrey A Kelman, Andrew D Mosholder, David J Graham
PURPOSE: In the United States, the National Death Index (NDI) is the most complete source of death information, while epidemiologic studies with mortality outcomes often rely on U.S. Medicare data for outcome ascertainment. The purpose of this study was to assess the agreement of death information between the Centers for Medicare & Medicaid Services (CMS) Medicare enrolment data and NDI. METHODS: Using Medicare and NDI data from 1999 through 2016, we identified Medicare beneficiaries who were reported dead in the CMS Medicare enrolment database (EDB) and Common Medicare Environment (CME), linked these beneficiaries to the NDI using CMS Health Insurance Claim number, and compared death dates between the two data sources...
March 2024: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38419165/risk-of-fall-or-fracture-with-concomitant-use-of-prescription-opioids-and-other-medications-in-osteoarthritis-patients
#20
JOURNAL ARTICLE
Nazleen F Khan, Katsiaryna Bykov, Jeffrey N Katz, Robert J Glynn, Seanna M Vine, Seoyoung C Kim
BACKGROUND: Osteoarthritis (OA) patients taking prescription opioids for pain are at increased risk of fall or fracture, and the concomitant use of interacting drugs may further increase the risk of these events. AIMS: To identify prescription opioid-related medication combinations associated with fall or fracture. MATERIALS & METHODS: We conducted a case-crossover-based screening of two administrative claims databases spanning 2003 through 2021...
March 2024: Pharmacoepidemiology and Drug Safety
journal
journal
31040
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.